Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.21) by 47.62 percent. This is a 47.62 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $34.319 million which missed the analyst consensus estimate of $37.200 million by 7.74 percent. This is a 44.56 percent decrease over sales of $61.898 million the same period last year.